Incyte to Present at Upcoming Investor Conferences
Incyte to Present at Upcoming Investor Conferences
May 27, 2010 at 8:00 AM EDT
WILMINGTON, Del., May 27, 2010 (BUSINESS WIRE) --Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences:
- Jefferies 2010 Global Life Sciences Conference on Wednesday, June 9, 2010 at 2:30 p.m. (ET) in New York City and
- Goldman Sachs 31st Annual Global Healthcare Conference on Tuesday, June 15, 2010 at 9:45 a.m. (PT) / 12:45 p.m. (ET) in Los Angeles.
The presentations will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentations will be available for 30 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. Incyte's most advanced compound, INCB18424, is in Phase III development for myelofibrosis. For additional information on Incyte, visit the Company's web site at www.incyte.com.
SOURCE: Incyte Corporation
Incyte Pamela M. Murphy Vice President, Investor Relations/Corporate Communications 302-498-6944